Loading…
Validation and implementation of a commercial real‐time PCR assay for direct detection of Candida auris from surveillance samples
Background Rapid and reliable laboratory methods are required for detecting the nosocomial yeast Candida auris. AurisID® (Olm Diagnostics) is a real‐time PCR assay approved for detecting C. auris in fungal cultures and directly from blood samples, involving a nucleic acid extraction as a prior step....
Saved in:
Published in: | Mycoses 2021-06, Vol.64 (6), p.612-615 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3530-2f4b359cbd868520bfa8eeb9f1ea161beb7c3821067cd0a35e82545e2f6977d03 |
---|---|
cites | cdi_FETCH-LOGICAL-c3530-2f4b359cbd868520bfa8eeb9f1ea161beb7c3821067cd0a35e82545e2f6977d03 |
container_end_page | 615 |
container_issue | 6 |
container_start_page | 612 |
container_title | Mycoses |
container_volume | 64 |
creator | Mulet Bayona, Juan V. Salvador García, Carme Tormo Palop, Nuria Gimeno Cardona, Concepción |
description | Background
Rapid and reliable laboratory methods are required for detecting the nosocomial yeast Candida auris. AurisID® (Olm Diagnostics) is a real‐time PCR assay approved for detecting C. auris in fungal cultures and directly from blood samples, involving a nucleic acid extraction as a prior step.
Objectives
The purpose of this study is to validate the AurisID® kit for direct detection of C. auris from surveillance samples without prior DNA extraction and to analyse the results of implementing this methodology to our daily laboratory routine protocol for C. auris surveillance studies.
Methods
Our PCR method using the AurisID® kit was compared with our routine protocol, consisting of culture in CHROMagar® Candida and identification by mass spectrometry. A total of 113 swabs were used for validation and 136 pair of surveillance samples were tested. Limit of detection (LOD) was determined by using swabs in Amies transport medium, which were spiked in a series of dilutions of a C. auris standardised suspension (0.5 McFarland).
Results
The PCR method showed high sensitivity, specificity, predictive positive value and predictive negative value (96.6%, 100%, 100% and 98.2%, respectively) when compared with the routine protocol. LOD was 500 CFU/ml, which corresponds to approximately 1 CFU/PCR.
Conclusions
Our PCR method using the AurisID® kit allows a reduction in the turnaround time for surveillance of C. auris compared with other methods. These results are expected to contribute to control C. auris outbreaks, allowing isolation of patients and cleaning of environmental surfaces in advance. |
doi_str_mv | 10.1111/myc.13250 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2486145885</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2486145885</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3530-2f4b359cbd868520bfa8eeb9f1ea161beb7c3821067cd0a35e82545e2f6977d03</originalsourceid><addsrcrecordid>eNp1kctq3TAQhkVpaU6TLPICQdBNsnCii2XLy2JyKaS0lCSQlZDlEShY1qlkN5xdoC_QZ-yTVKc-6aJQbQbEN98M8yN0RMkZze_cb8wZ5UyQV2hFS94URJD6NVqRhvOiLkm9h96l9EgIrRtWvUV7nAvW8Eau0I97PbheTy6MWI89dn49gIdxWr6CxRqb4D1E4_SAI-jh1_PPyXnAX9qvWKekN9iGiHsXwUy4hymXXWubjVmO9RxdwjYGj9Mcv4MbBj0awElvp6UD9MbqIcHhru6ju8uL2_a6uPl89bH9cFMYLjgpmC07LhrT9bKSgpHOagnQNZaCphXtoKsNl4ySqjY90VyAZKIUwGzV1HVP-D46WbzrGL7NkCblXTKwXQbCnBQrZUVLIaXI6Pt_0McwxzFvp5hgJck3pSxTpwtlYkgpglXr6LyOG0WJ2iajcjLqTzKZPd4Z585D_5d8iSID5wvw5AbY_N-kPj20i_I3yx2Zww</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2524040712</pqid></control><display><type>article</type><title>Validation and implementation of a commercial real‐time PCR assay for direct detection of Candida auris from surveillance samples</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Mulet Bayona, Juan V. ; Salvador García, Carme ; Tormo Palop, Nuria ; Gimeno Cardona, Concepción</creator><creatorcontrib>Mulet Bayona, Juan V. ; Salvador García, Carme ; Tormo Palop, Nuria ; Gimeno Cardona, Concepción</creatorcontrib><description>Background
Rapid and reliable laboratory methods are required for detecting the nosocomial yeast Candida auris. AurisID® (Olm Diagnostics) is a real‐time PCR assay approved for detecting C. auris in fungal cultures and directly from blood samples, involving a nucleic acid extraction as a prior step.
Objectives
The purpose of this study is to validate the AurisID® kit for direct detection of C. auris from surveillance samples without prior DNA extraction and to analyse the results of implementing this methodology to our daily laboratory routine protocol for C. auris surveillance studies.
Methods
Our PCR method using the AurisID® kit was compared with our routine protocol, consisting of culture in CHROMagar® Candida and identification by mass spectrometry. A total of 113 swabs were used for validation and 136 pair of surveillance samples were tested. Limit of detection (LOD) was determined by using swabs in Amies transport medium, which were spiked in a series of dilutions of a C. auris standardised suspension (0.5 McFarland).
Results
The PCR method showed high sensitivity, specificity, predictive positive value and predictive negative value (96.6%, 100%, 100% and 98.2%, respectively) when compared with the routine protocol. LOD was 500 CFU/ml, which corresponds to approximately 1 CFU/PCR.
Conclusions
Our PCR method using the AurisID® kit allows a reduction in the turnaround time for surveillance of C. auris compared with other methods. These results are expected to contribute to control C. auris outbreaks, allowing isolation of patients and cleaning of environmental surfaces in advance.</description><identifier>ISSN: 0933-7407</identifier><identifier>EISSN: 1439-0507</identifier><identifier>DOI: 10.1111/myc.13250</identifier><identifier>PMID: 33529398</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Candida ; Candida auris ; colonisation ; Hospitals ; Laboratories ; Mass spectroscopy ; Polymerase chain reaction ; Surveillance ; Transport media ; yeasts</subject><ispartof>Mycoses, 2021-06, Vol.64 (6), p.612-615</ispartof><rights>2021 Wiley‐VCH GmbH</rights><rights>2021 Wiley-VCH GmbH.</rights><rights>2021 Blackwell Verlag GmbH</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3530-2f4b359cbd868520bfa8eeb9f1ea161beb7c3821067cd0a35e82545e2f6977d03</citedby><cites>FETCH-LOGICAL-c3530-2f4b359cbd868520bfa8eeb9f1ea161beb7c3821067cd0a35e82545e2f6977d03</cites><orcidid>0000-0003-0678-9068</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33529398$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mulet Bayona, Juan V.</creatorcontrib><creatorcontrib>Salvador García, Carme</creatorcontrib><creatorcontrib>Tormo Palop, Nuria</creatorcontrib><creatorcontrib>Gimeno Cardona, Concepción</creatorcontrib><title>Validation and implementation of a commercial real‐time PCR assay for direct detection of Candida auris from surveillance samples</title><title>Mycoses</title><addtitle>Mycoses</addtitle><description>Background
Rapid and reliable laboratory methods are required for detecting the nosocomial yeast Candida auris. AurisID® (Olm Diagnostics) is a real‐time PCR assay approved for detecting C. auris in fungal cultures and directly from blood samples, involving a nucleic acid extraction as a prior step.
Objectives
The purpose of this study is to validate the AurisID® kit for direct detection of C. auris from surveillance samples without prior DNA extraction and to analyse the results of implementing this methodology to our daily laboratory routine protocol for C. auris surveillance studies.
Methods
Our PCR method using the AurisID® kit was compared with our routine protocol, consisting of culture in CHROMagar® Candida and identification by mass spectrometry. A total of 113 swabs were used for validation and 136 pair of surveillance samples were tested. Limit of detection (LOD) was determined by using swabs in Amies transport medium, which were spiked in a series of dilutions of a C. auris standardised suspension (0.5 McFarland).
Results
The PCR method showed high sensitivity, specificity, predictive positive value and predictive negative value (96.6%, 100%, 100% and 98.2%, respectively) when compared with the routine protocol. LOD was 500 CFU/ml, which corresponds to approximately 1 CFU/PCR.
Conclusions
Our PCR method using the AurisID® kit allows a reduction in the turnaround time for surveillance of C. auris compared with other methods. These results are expected to contribute to control C. auris outbreaks, allowing isolation of patients and cleaning of environmental surfaces in advance.</description><subject>Candida</subject><subject>Candida auris</subject><subject>colonisation</subject><subject>Hospitals</subject><subject>Laboratories</subject><subject>Mass spectroscopy</subject><subject>Polymerase chain reaction</subject><subject>Surveillance</subject><subject>Transport media</subject><subject>yeasts</subject><issn>0933-7407</issn><issn>1439-0507</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kctq3TAQhkVpaU6TLPICQdBNsnCii2XLy2JyKaS0lCSQlZDlEShY1qlkN5xdoC_QZ-yTVKc-6aJQbQbEN98M8yN0RMkZze_cb8wZ5UyQV2hFS94URJD6NVqRhvOiLkm9h96l9EgIrRtWvUV7nAvW8Eau0I97PbheTy6MWI89dn49gIdxWr6CxRqb4D1E4_SAI-jh1_PPyXnAX9qvWKekN9iGiHsXwUy4hymXXWubjVmO9RxdwjYGj9Mcv4MbBj0awElvp6UD9MbqIcHhru6ju8uL2_a6uPl89bH9cFMYLjgpmC07LhrT9bKSgpHOagnQNZaCphXtoKsNl4ySqjY90VyAZKIUwGzV1HVP-D46WbzrGL7NkCblXTKwXQbCnBQrZUVLIaXI6Pt_0McwxzFvp5hgJck3pSxTpwtlYkgpglXr6LyOG0WJ2iajcjLqTzKZPd4Z585D_5d8iSID5wvw5AbY_N-kPj20i_I3yx2Zww</recordid><startdate>202106</startdate><enddate>202106</enddate><creator>Mulet Bayona, Juan V.</creator><creator>Salvador García, Carme</creator><creator>Tormo Palop, Nuria</creator><creator>Gimeno Cardona, Concepción</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0678-9068</orcidid></search><sort><creationdate>202106</creationdate><title>Validation and implementation of a commercial real‐time PCR assay for direct detection of Candida auris from surveillance samples</title><author>Mulet Bayona, Juan V. ; Salvador García, Carme ; Tormo Palop, Nuria ; Gimeno Cardona, Concepción</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3530-2f4b359cbd868520bfa8eeb9f1ea161beb7c3821067cd0a35e82545e2f6977d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Candida</topic><topic>Candida auris</topic><topic>colonisation</topic><topic>Hospitals</topic><topic>Laboratories</topic><topic>Mass spectroscopy</topic><topic>Polymerase chain reaction</topic><topic>Surveillance</topic><topic>Transport media</topic><topic>yeasts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mulet Bayona, Juan V.</creatorcontrib><creatorcontrib>Salvador García, Carme</creatorcontrib><creatorcontrib>Tormo Palop, Nuria</creatorcontrib><creatorcontrib>Gimeno Cardona, Concepción</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Mycoses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mulet Bayona, Juan V.</au><au>Salvador García, Carme</au><au>Tormo Palop, Nuria</au><au>Gimeno Cardona, Concepción</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Validation and implementation of a commercial real‐time PCR assay for direct detection of Candida auris from surveillance samples</atitle><jtitle>Mycoses</jtitle><addtitle>Mycoses</addtitle><date>2021-06</date><risdate>2021</risdate><volume>64</volume><issue>6</issue><spage>612</spage><epage>615</epage><pages>612-615</pages><issn>0933-7407</issn><eissn>1439-0507</eissn><abstract>Background
Rapid and reliable laboratory methods are required for detecting the nosocomial yeast Candida auris. AurisID® (Olm Diagnostics) is a real‐time PCR assay approved for detecting C. auris in fungal cultures and directly from blood samples, involving a nucleic acid extraction as a prior step.
Objectives
The purpose of this study is to validate the AurisID® kit for direct detection of C. auris from surveillance samples without prior DNA extraction and to analyse the results of implementing this methodology to our daily laboratory routine protocol for C. auris surveillance studies.
Methods
Our PCR method using the AurisID® kit was compared with our routine protocol, consisting of culture in CHROMagar® Candida and identification by mass spectrometry. A total of 113 swabs were used for validation and 136 pair of surveillance samples were tested. Limit of detection (LOD) was determined by using swabs in Amies transport medium, which were spiked in a series of dilutions of a C. auris standardised suspension (0.5 McFarland).
Results
The PCR method showed high sensitivity, specificity, predictive positive value and predictive negative value (96.6%, 100%, 100% and 98.2%, respectively) when compared with the routine protocol. LOD was 500 CFU/ml, which corresponds to approximately 1 CFU/PCR.
Conclusions
Our PCR method using the AurisID® kit allows a reduction in the turnaround time for surveillance of C. auris compared with other methods. These results are expected to contribute to control C. auris outbreaks, allowing isolation of patients and cleaning of environmental surfaces in advance.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>33529398</pmid><doi>10.1111/myc.13250</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-0678-9068</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0933-7407 |
ispartof | Mycoses, 2021-06, Vol.64 (6), p.612-615 |
issn | 0933-7407 1439-0507 |
language | eng |
recordid | cdi_proquest_miscellaneous_2486145885 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Candida Candida auris colonisation Hospitals Laboratories Mass spectroscopy Polymerase chain reaction Surveillance Transport media yeasts |
title | Validation and implementation of a commercial real‐time PCR assay for direct detection of Candida auris from surveillance samples |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T21%3A56%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Validation%20and%20implementation%20of%20a%20commercial%20real%E2%80%90time%20PCR%20assay%20for%20direct%20detection%20of%20Candida%20auris%20from%20surveillance%20samples&rft.jtitle=Mycoses&rft.au=Mulet%20Bayona,%20Juan%20V.&rft.date=2021-06&rft.volume=64&rft.issue=6&rft.spage=612&rft.epage=615&rft.pages=612-615&rft.issn=0933-7407&rft.eissn=1439-0507&rft_id=info:doi/10.1111/myc.13250&rft_dat=%3Cproquest_cross%3E2486145885%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3530-2f4b359cbd868520bfa8eeb9f1ea161beb7c3821067cd0a35e82545e2f6977d03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2524040712&rft_id=info:pmid/33529398&rfr_iscdi=true |